Works by Janzen, Tilman

Results: 7

Experience of rescue therapy with [177Lu]Lu-rhPSMA-10.1 in patients with primary or acquired resistance to [177Lu]Lu-PSMA-I&T.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 3, p. 970, doi. 10.1007/s00259-024-06959-5

By:

Gäble, Alexander;
Dierks, Alexander;
Rinscheid, Andreas;
Patt, Marianne;
Wienand, Georgine;
Pfob, Christian H.;
Kircher, Malte;
Fukushima, Kazuhito;
Nikolić, Ana Antić;
Enke, Johanna S.;
Janzen, Tilman;
Steinestel, Julie;
Kempter, Hildegard;
Trepel, Martin;
Weckermann, Dorothea;
Lapa, Constantin;
Bundschuh, Ralph A.

Publication type:

Article

[99mTc]Tc-PentixaTec: development, extensive pre-clinical evaluation, and first human experience.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 13, p. 3937, doi. 10.1007/s00259-023-06395-x

By:

Konrad, Matthias;
Rinscheid, Andreas;
Wienand, Georgine;
Nittbaur, Bernd;
Wester, Hans-Jürgen;
Janzen, Tilman;
Lapa, Constantin;
Pfob, Christian Helmut;
Schottelius, Margret

Publication type:

Article

First Safety and Efficacy Data with the Radiohybrid 177Lu-rhPSMA-10.1 for the Treatment of Metastatic Prostate Cancer.

Published in:

Journal of Nuclear Medicine, 2024, v. 65, n. 3, p. 432, doi. 10.2967/jnumed.123.266741

By:

Dierks, Alexander;
Gäble, Alexander;
Rinscheid, Andreas;
Wienand, Georgine;
Pfob, Christian H.;
Kircher, Malte;
Enke, Johanna S.;
Janzen, Tilman;
Patt, Marianne;
Trepel, Martin;
Weckermann, Dorothea;
Bundschuh, Ralph A.;
Lapa, Constantin

Publication type:

Article

A Compartmental Model for Biokinetics and Dosimetry of 18F-Choline in Prostate Cancer Patients.

Published in:

Journal of Nuclear Medicine, 2012, v. 53, n. 6, p. 985, doi. 10.2967/jnumed.111.099408

By:

Giussani, Augusto;
Janzen, Tilman;
Uusijärvi-Lizana, Helena;
Tavola, Federico;
Zankl, Maria;
Sydoff, Marie;
Bjartell, Anders;
Leide-Svegborn, Sigrid;
Söderberg, Marcus;
Mattsson, Sören;
Hoeschen, Christoph;
Cantone, Marie-Claire

Publication type:

Article

Intraoperative radiotherapy after neurosurgical resection of brain metastases as institutional standard treatment– update of the oncological outcome form a single center cohort after 117 procedures.

Published in:

Journal of Neuro-Oncology, 2024, v. 169, n. 1, p. 187, doi. 10.1007/s11060-024-04691-6

By:

Kahl, Klaus-Henning;
Krauss, Philipp E.;
Neu, Maria;
Maurer, Christoph J.;
Schill-Reiner, Sabine;
Roushan, Zoha;
Laukmanis, Eva;
Dobner, Christian;
Janzen, Tilman;
Balagiannis, Nikolaos;
Sommer, Björn;
Stüben, Georg;
Shiban, Ehab

Publication type:

Article

Focal cavity radiotherapy after neurosurgical resection of brain metastases: sparing neurotoxicity without compromising locoregional control.

Published in:

Strahlentherapie und Onkologie, 2022, v. 198, n. 12, p. 1105, doi. 10.1007/s00066-022-02003-3

By:

Kahl, Klaus-Henning;
Shiban, Ehab;
Gutser, Susanne;
Maurer, Christoph J.;
Sommer, Björn;
Müller, Heiko;
Konietzko, Ina;
Grossert, Ute;
Berlis, Ansgar;
Janzen, Tilman;
Stüben, Georg

Publication type:

Article

Intraoperative radiotherapy with low-energy x-rays after neurosurgical resection of brain metastases—an Augsburg University Medical Center experience.

Published in:

Strahlentherapie und Onkologie, 2021, v. 197, n. 12, p. 1124, doi. 10.1007/s00066-021-01831-z

By:

Kahl, Klaus-Henning;
Balagiannis, Nikolaos;
Höck, Michael;
Schill, Sabine;
Roushan, Zoha;
Shiban, Ehab;
Müller, Heiko;
Grossert, Ute;
Konietzko, Ina;
Sommer, Björn;
Maurer, Christoph J.;
Berlis, Ansgar;
Heidecke, Volkmar;
Janzen, Tilman;
Stüben, Georg

Publication type:

Article

Works by Janzen, Tilman

Experience of rescue therapy with [<sup>177</sup>Lu]Lu-rhPSMA-10.1 in patients with primary or acquired resistance to [<sup>177</sup>Lu]Lu-PSMA-I&T.

[<sup>99m</sup>Tc]Tc-PentixaTec: development, extensive pre-clinical evaluation, and first human experience.

First Safety and Efficacy Data with the Radiohybrid <sup>177</sup>Lu-rhPSMA-10.1 for the Treatment of Metastatic Prostate Cancer.

A Compartmental Model for Biokinetics and Dosimetry of <sup>18</sup>F-Choline in Prostate Cancer Patients.

Intraoperative radiotherapy after neurosurgical resection of brain metastases as institutional standard treatment– update of the oncological outcome form a single center cohort after 117 procedures.

Focal cavity radiotherapy after neurosurgical resection of brain metastases: sparing neurotoxicity without compromising locoregional control.

Intraoperative radiotherapy with low-energy x-rays after neurosurgical resection of brain metastases—an Augsburg University Medical Center experience.